the long run, and consolidate Sihuan Pharmaceutical's leadership in the CCV drug market. " Scope of the agreement Under the terms of the agreement Sihuan is responsible for clinical development, regulatory and market approval, market access and promotion as well as marketing, distribution and sales in

. CicloMulsion° and NeuroSTAr contain cyclosporine which, by inhibiting cyclophilin D, prevents the disruption of the membrane of the mitochondria. Sihuan is a leading Chinese pharmaceutical company with the largest cardio-cerebral vascular drug franchise in China. It has a proven track record in R&D,